Analysis of amphotericin B-induced cell signaling with chemical inhibitors of signaling molecules

Microbiology and Immunology

Volumn 50, Issue 4, 2006, Pages 337-347

  Matsuo, Kenichiro ^a   Hotokezaka, Hitoshi ^a   Ohara, Naoya ^a   Fujimura, Yuji ^a   Yoshimura, Atsutoshi ^a   Okada, Yukio ^a   Hara, Yoshitaka ^a   Yoshida, Noriaki ^a   Nakayama, Koji ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Amphotericin B; Cell signaling; Phospholipase C; Toll like receptor

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; AMPHOTERICIN B; BRUTON TYROSINE KINASE; CALCIUM CHELATING AGENT; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; PEPTIDOGLYCAN; PHOSPHOLIPASE C; PHOSPHOLIPASE C INHIBITOR; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; SIGNAL PEPTIDE; SYNAPTOTAGMIN I; TOLL LIKE RECEPTOR 2; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; AGAMMAGLOBULINAEMIA TYROSINE KINASE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; PROTEIN TYROSINE KINASE C SRC; PROTEIN-TYROSINE KINASE C-SRC; TOLL LIKE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELLULAR DISTRIBUTION; CHEMOTHERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; DRUG TARGETING; IMMUNOSTIMULATION; INFLAMMATION; MALE; MONOCYTE; MOUSE; NONHUMAN; NUCLEAR IMPORT; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; ACTIVE TRANSPORT; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL NUCLEUS; CHO CELL; DRUG ANTAGONISM; DRUG EFFECT; HAMSTER; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

MUS;

ACTIVE TRANSPORT, CELL NUCLEUS; AMPHOTERICIN B; ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CELL NUCLEUS; CHO CELLS; CRICETINAE; CYTOKINES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED BALB C; MONOCYTES; PHOSPHOLIPASE C; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTOR RELA;

EID: 33745119045     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2006.tb03792.x     Document Type: Article

References (26)

1. Arning, M., Kliche, K.O., Heer-Sonderhoff, A.H., and Wehmeier, A. 1995. Infusion-related toxicity of three different amphotericin B formulations and its relation to cytokine plasma levels. Mycoses 38: 459-465.
2. Cario, E., Gerken, G., and Podolsky, D.K. 2004. Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology 127: 224-238.
3. Chang, Y.J., Wu, M.S., Lin, J.T., Sheu, B.S., Muta, T., Inoue, H., and Chen, C.C. 2004. Induction of cyclooxygenase-2 overexpression in human gastric epithelial cells by Helicobacter pylori involves TLR2/TLR9 and c-Src-dependent nuclear factor-kappaB activation. Mol. Pharmacol. 66: 1465-1477.
4. Chia, J.K., and Pollack, M. 1989. Amphotericin B induces tumor necrosis factor production by murine macrophages. J. Infect. Dis. 159: 113-116.
5. Cleary, J.D., Chapman, S.W., and Nolan, R.L. 1992. Pharmacologic modulation of interleukin-1 expression by amphotericin B-stimulated human mononuclear cells. Antimicrob. Agents Chemother. 36: 977-981.
6. Cleary, J.D., Weisdorf, D., and Fletcher, C.V. 1988. Effect of infusion rate on amphotericin B-associated febrile reactions. Drug Intell. Clin. Pharm. 22: 769-772.
7. Cohen, B.E. 1986. Concentration- and time-dependence of amphotericin-B induced permeability changes across ergosterol-containing liposomes. Biochim. Biophys. Acta 857: 117-122.
8. Cohen, B.E., Benaim, G., Ruiz, M.C., and Michelangeli, F. 1990. Increased calcium permeability is not responsible for the rapid lethal effects of amphotericin B on Leishmania sp. FEBS Lett. 259: 286-288.
9. Cohen, B.E., and Gamargo, M. 1987. Concentration and time dependence of amphotericin B-induced permeability changes across plasma membrane vesicles from Leishmania sp. Drugs Exp. Clin. Res. 13: 539-546.
10. Delude, R.L., Yoshimura, A., Ingalls, R.R., and Golenbock, D.T. 1998. Construction of a lipopolysaccharide reporter cell line and its use in identifying mutants defective in endotoxin, but not TNF-alpha, signal transduction. J. Immunol. 161: 3001-3009.
11. Dixit, V., and Mak, T.W. 2002. NF-kappaB signaling. Many roads lead to Madrid. Cell 111: 615-619.
12. Gigliotti, F., Shenep, J.L., Lott, L., and Thornton, D. 1987. Induction of prostaglandin synthesis as the mechanism responsible for the chills and fever produced by infusing amphotericin B. J. Infect. Dis. 156: 784-789.
13. Heine, H., Kirschning, C.J., Lien, E., Monks, B.G., Rothe, M., and Golenbock, D.T. 1999. Cutting edge: cells that carry A null allele for toll-like receptor 2 are capable of responding to endotoxin. J. Immunol. 162: 6971-6975.
14. Jefferies, C.A., Doyle, S., Brunner, C., Dunne, A., Brint, E., Wietek, C., Walch, E., Wirth, T., and O'Neill, L.A. 2003. Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4. J. Biol. Chem. 278: 26258-26264.
15. Kim, Y.J., Sekiya, F., Poulin, B., Bae, Y.S., and Rhee, S.G. 2004. Mechanism of B-cell receptor-induced phosphorylation and activation of phospholipase C-gamma2. Mol. Cell. Biol. 24: 9986-9999.
16. Lemke, A., Kiderlen, A.F., and Kayser, O. 2005. Amphotericin B. Appl. Microbiol. Biotechnol. 68: 151-162.
17. 2+ in complement membrane attack. Cell Calcium 7: 399-411.
18. Nishizuka, Y. 1995. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 9: 484-496.
19. Ostrosky-Zeichner, L., Marr, K.A., Rex, J.H., and Cohen, S.H. 2003. Amphotericin B: time for a new "gold standard." Clin. Infect. Dis. 37: 415-425.
20. Pomerantz, J.L., and Baltimore, D. 2002. Two pathways to NF-kappaB. Mol. Cell 10: 693-695.
21. 2+ ionophore in sterol-containing liposomes. Biochim. Biophys. Acta 982: 303-306.
22. Razonable, R.R., Henault, M., Lee, L.N., Laethem, C., Johnston, P.A., Watson, H.L., and Paya, C.V. 2005. Secretion of proinflammatory cytokines and chemokines during amphotericin B exposure is mediated by coactivation of toll-like receptors 1 and 2. Antimicrob. Agents Chemother. 49: 1617-1621.
23. Sau, K., Mambula, S.S., Latz, E., Henneke, P., Golenbock, D.T., and Levitz, S.M. 2003. The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism. J. Biol. Chem. 278: 37561-37568.
24. Sawaya, B.P., Briggs, J.P., and Schnermann, J. 1995. Amphotericin B nephrotoxicity: the adverse consequences of altered membrane properties. J. Am. Soc. Nephrol. 6: 154-164.
25. Schanne, F.A., Kane, A.B., Young, E.E., and Farber, J.L. 1979. Calcium dependence of toxic cell death: a final common pathway. Science 206: 700-702.
26. Zager, R.A. 2000. Polyene antibiotics: relative degrees of in vitro cytotoxicity and potential effects on tubule phospholipid and ceramide content. Am. J. Kidney Dis. 36: 238-249.